Osteopore Ltd
ASX:OSX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.006
0.037
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Osteopore Ltd
Osteopore Ltd. develops and markets bioresorbable polymer implants for neurosurgical, orthopaedic and maxillofacial surgeries. The company is headquartered in Perth, Western Australia. The company went IPO on 2019-09-23. The firm is engaged in commercializing a range of products to facilitate bone healing across multiple therapeutic areas. The company fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material using its platform technology. Its 3D print scaffold design is based on the principle of tissue engineering and regenerative medicine. Its craniofacial products include Osteomesh, Osteoplug, and Osteoplug-C. Its craniofacial products are used as bone void fillers for regeneration of natural bone. The company also develops and manufactures implants that focuses on unmet clinical needs which improve patient outcomes. Its science of tissue engineering and regenerative medicine provides various surgical solutions for medical surgeons. Its products are used by surgeons across Asia, Europe, Australia, and the Americas.
Osteopore Ltd. develops and markets bioresorbable polymer implants for neurosurgical, orthopaedic and maxillofacial surgeries. The company is headquartered in Perth, Western Australia. The company went IPO on 2019-09-23. The firm is engaged in commercializing a range of products to facilitate bone healing across multiple therapeutic areas. The company fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material using its platform technology. Its 3D print scaffold design is based on the principle of tissue engineering and regenerative medicine. Its craniofacial products include Osteomesh, Osteoplug, and Osteoplug-C. Its craniofacial products are used as bone void fillers for regeneration of natural bone. The company also develops and manufactures implants that focuses on unmet clinical needs which improve patient outcomes. Its science of tissue engineering and regenerative medicine provides various surgical solutions for medical surgeons. Its products are used by surgeons across Asia, Europe, Australia, and the Americas.